Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

290 results

  1. INDUSTRY|chemistry · LAW|criminal law|offence · SOCIAL QUESTIONS|health|medical science
    MDA Reference Faofa ag an gCoiste Téarmaíochta, www.tearma.ie ;Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    meitiléindé-ocsamfataimín Reference Faofa ag an gCoiste Téarmaíochta, www.tearma.ie ;Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    3,4 Methylendioxyamphetamin | Methylendioxyamphetamin | Methyldioxyamphetamin | MDA
    de
    "Mellow Drug of America" | methylenedioxyamphetamine | MDA
    en
    MDA | pilule d'amour | méthylènedioxamphétamine
    fr
    Definition hallucinogène synthétique Reference Term.drogues
  2. SOCIAL QUESTIONS|health|pharmaceutical industry
    (1R)-1,2-ainhidrea-4-C-(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carbocsalátai-4-cioglaiheiptilpipioraisin-2-il)-6,9-déhiodrocsa-2,6-démheitiol-11-ocsó-ocsaiciogladóideic-3-éin-1-il]peinti-1,3-dé-éin-1-il-3,5-dédí-ocsa-1-[(2R,3S)-3-hiodrocsaipeintin-2-il]-D-eiritripeinteatól Reference Fiontar, DCU
    ga
    (1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol
    en
  3. SOCIAL QUESTIONS|health|pharmaceutical industry
    (1S)-1,5:7,10-dé-ainhidri-12,13-bis-O-[treas-bhúitil(démheitil)silil]-2,3,4,6,8,11-heicsead-ocsai-1-2- [(2S,5S)-5-(3-hiodrocsapróipil)-3-meitilidéinteitrihidreafúráin-2-il]eitil-3-meitil-9-O- meitil-4-meitilidéin-8-[(feiniolsulfáinil)meitiol-D-arabanó-D-altra-trídeiceatól Reference Fiontar, DCU
    ga
    (1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylidene-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol
    en
  4. SOCIAL QUESTIONS|health|pharmaceutical industry
    (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trífhluaraimeitil)feinil]eatocsa}-3-(2-fluaraifeinil)morfóilin-4-il]meitil}-5-ocsói-2,5-déhidri-1H-1,2,4-trí-asóil-1-il)aigéad fosfónach --1-dí-ocsa-1-(meitiolaimín)-D-glúicíotól Reference Fiontar, DCU
    ga
    (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid -- 1-deoxy-1-(methylamino)-D-glucitol (1:2)
    en